Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hedner

Showing results (21-30 of 242) with videos related to

Pageof 25
Sort By:
Seminars in Thrombosis and Hemostasis|November 25, 2000
Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000U Hedner
Journal of Thrombosis and Haemostasis : JTH|August 16, 2006
Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitorsU Hedner
Thrombosis Research|March 15, 1989
Potentiated thrombolysis in a Chandler system using rtPA and lys-plasminogenJ Ljungberg, U Hedner
Thrombosis Research|June 1, 1978
Inhibition of activated Hageman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor)U Hedner, G Martinsson
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1983
Pregnancy and venous thrombo-embolismD Bergqvist, U Hedner
Transfusion Science|May 7, 1998
Clinical use of recombinant FVIIa (rFVIIa)U Hedner, J Ingerslev
Haemostasis|January 1, 1988
Characterizing hereditary and acquired defects of plasminogenU Hedner, L Tengborn
Annals of Medicine|February 24, 2001
Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPIU Hedner, E Erhardtsen
Hematology/Oncology Clinics of North America|October 1, 1992
Management of hemophilia patients with inhibitorsU Hedner, S Glazer
Ophthalmology|July 1, 1984
The effect of sodium hyaluronate and sodium chondroitin sulfate on the coagulation system in vitroM Pandolfi, U Hedner
Pageof 25

Showing results (21-30 of 242) with videos related to

Sort By:
Pageof 25
Seminars in Thrombosis and Hemostasis|November 25, 2000
Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000U Hedner
Journal of Thrombosis and Haemostasis : JTH|August 16, 2006
Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitorsU Hedner
Thrombosis Research|March 15, 1989
Potentiated thrombolysis in a Chandler system using rtPA and lys-plasminogenJ Ljungberg, U Hedner
Thrombosis Research|June 1, 1978
Inhibition of activated Hageman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor)U Hedner, G Martinsson
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1983
Pregnancy and venous thrombo-embolismD Bergqvist, U Hedner
Transfusion Science|May 7, 1998
Clinical use of recombinant FVIIa (rFVIIa)U Hedner, J Ingerslev
Haemostasis|January 1, 1988
Characterizing hereditary and acquired defects of plasminogenU Hedner, L Tengborn
Annals of Medicine|February 24, 2001
Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPIU Hedner, E Erhardtsen
Hematology/Oncology Clinics of North America|October 1, 1992
Management of hemophilia patients with inhibitorsU Hedner, S Glazer
Ophthalmology|July 1, 1984
The effect of sodium hyaluronate and sodium chondroitin sulfate on the coagulation system in vitroM Pandolfi, U Hedner
Pageof 25